Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Kidney Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Cisplatin 3selpercatinib 2pembrolizumab 2Etoposide 2Carboplatin 2regorafenib 1pentetreotide 1pazopanib 1etoposide phosphate 1epothilone B 1entrectinib 1durvalumab 1carbon-11 methionine 1cabozantinib 1aflibercept 1Thiotepa 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1NEO212 1Molecular Diagnostic Techniques 1Methionine 1MLN 8237 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Genetic Testing × Head & Neck × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡